US approves drug to prevent HIV infection

Published: 17th July 2012 01:21 PM  |   Last Updated: 17th July 2012 01:21 PM   |  A+A-


The US Monday approved Truvada, the first drug approved to reduce the risk of HIV infection in uninfected individuals who are at high risk of infection and who may engage in sexual activity with HIV-infected partners.

The daily pill Truvada, made by California-based Gilead Sciences, combines two medicines that inhibit the reproduction of HIV. It's supposed to be used in combination with safe-sex practices to reduce infection risk, reported Xinhua.

"Truvada alone shouldn't be used to prevent HIV infection," US Food and Drug Administration (FDA)'s Debra Birnkrant said in a media briefing.

The FDA previously approved Truvada to be used in combination with other antiretroviral agents for the treatment of HIV-infected adults and children 12 years or older.

People taking Truvada should be tested for HIV infection every three months, so treatment could begin promptly if an infection has occurred, according to the FDA.

"Today's approval marks an important milestone in our fight against HIV," said FDA Commissioner Margaret Hamburg in a statement.

"Every year, about 50,000 US adults and adolescents are diagnosed with HIV infection ... New treatments as well as prevention methods are needed to fight the HIV epidemic in this country."

Stay up to date on all the latest World news with The New Indian Express App. Download now
(Get the news that matters from New Indian Express on WhatsApp. Click this link and hit 'Click to Subscribe'. Follow the instructions after that.)


Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on are those of the comment writers alone. They do not represent the views or opinions of or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp